Find the latest pharmaceutical market place for formulations enquiry about Insulin Lispro on PharmaCompass.com.

Various Finished Dosage Formulations needed in Mexico [ENA13437]

A company that offers comprehensive medical services, from equipping hospitals, providing maintenance to medical equipment and making tests for various diseases is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The suppliers must support this enquiry with GMP.
1. Sitagliptin (50 mg) + Metformin (850 mg) Tablets. The required pack size is 56 Tablets per box.
2. Recombinant Origin NPH Insulin (100 UI in 10 ml) Vials.
3. Recombinant Origin Rapid-Acting Human Insulin (100 UI in 10 ml) Vials.
4. Enoxaparin Sodium (60 mg) Prefilled Syringes with and without safety devices.

Reply

26 Apr 2022

Various Finished Dosage Formulations needed in Vietnam [ENA12477]

A large pharmaceutical company based in India that deals in various segments such as gynecology, cardiovascular, diabetology, asthma, pediatric, CNS, GI and NSAIDs is looking for suppliers of Various Finished Dosage Formulations for commercial purposes. The Indian suppliers must support this enquiry with USFDA or EUGMP & European suppliers must support this enquiry with WHO GMP. The final market is South East Asian countries.
1. Cefuroxime (250 mg or 500 mg) Tablets
2. Human Insulin (100 IU/ ml) Injections
3. Milrinone (10 mg) Vials
4. Cefoperazone (1 g) + Sulbactam (1 g) Injections
5. Dexlansoprazole (30 mg & 60 mg) Tablets

Reply

21 Jan 2022